Albuterol MDI Essential Use Exemption To Be Discussed By Pulmonary Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Pulmonary-Allergy Drugs Advisory Committee will meet June 10 to consider the agency’s proposed rule removing the exemption for albuterol metered-dose inhalers containing chlorofluorocarbons.